Download Amniotic Membrane Transplantation

Amniotic Membrane Transplantation
Amniotic membrane tissue (AMT) is obtained from the placenta of women who
have given birth via Caesarean section, and is available commercially for use in
the management of a variety of ocular disorders. AMT is used primarily as a
substitute for conjunctival tissue following removal of pterygia and conjunctival
tumors, as well as in the management of non-healing defects in the surface layer
of the cornea, the corneal epithelium. Amniotic membrane transplantation has
also been demonstrated to be useful in the treatment of ocular discomfort
associated with swelling of the corneal epithelium.
Recurrent lesion covering the cornea (left). One month following removal of the
lesion and the application of amniotic membrane tissue to the site of excision, the
eye is non-inflamed and comfortable.
Information about Pterygia
Information about Amniotic Membrane Tissue (AMT)